MYCN and glioblastoma: In paediatric glioblastoma, H3F3A G34 mutations elevate MYCN expression via H3K36me3-dependent mechanisms, driving incurable cerebral hemispheric GBMs through MYCN overexpression in neural stem cell compartments [109,110].